EIR Biotherapies s.r.l.
1 clinical trials · Sponsor
◉ Watch EIR Biotherapies s.r.l.
| Record | Firm | Date |
|---|---|---|
| Phase I/IIa Study: RR001 Administered Following Chemotherapy Cycles for Patients With Locally Advanced Pancreatic Carcinoma (NCT06861452) | EIR Biotherapies s.r.l. | 2025-06-25 |
Track EIR Biotherapies s.r.l. automatically
Every clearance here is in the API, with alerts when new ones post.